Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3733037010 | Isoniazid and pyrazinamide and rifampicin only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3733038017 | Isoniazid and pyrazinamide and rifampin only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3733039013 | Product containing only isoniazid and pyrazinamide and rifampicin (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
2855271000001116 | Rifampicin + Isoniazid + Pyrazinamide (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
2855281000001119 | Rifampicin + Isoniazid + Pyrazinamide | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing only isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) | Is a | True | Rifampicin + Isoniazid + Pyrazinamide | Inferred relationship | Existential restriction modifier | |
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet | Is a | True | Rifampicin + Isoniazid + Pyrazinamide | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets